S100A9 and neoplasm: Cheng et al. [89] showed that tumor derived factors promote sustained Stat3-dependent upregulation of S100A9 in myeloid precursors, which results in inhibition of differentiation of dendritic cells and accumulation of myeloid-derived suppressor cells.